All In MedTech

FDA Clearance Tracker · P000039-S013

AMPLATZER MULTI-FENESTRATED SEPTAL OCCLUDER ? ?CRIBRIFORM? OCCLUDER

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 21, 2006 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P000039-S013
Device name
AMPLATZER MULTI-FENESTRATED SEPTAL OCCLUDER ? ?CRIBRIFORM? OCCLUDER
Applicant location
St. Paul, MN
Received
Nov 21, 2005
Decided
Sep 21, 2006
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P000039

Device type

Device class
Class III

Every decision under product code MAE

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE AMPLATZER MULTI-FENESTRATED SEPTAL OCCLUDER (?CRIBRIFORM? OCCLUDER). THE DEVICE IS INDICATED FOR THE CLOSURE OF MULTI-FENESTRATED (CRIBRIFORM) ATRIAL SEPTAL DEFECTS.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.